265 related articles for article (PubMed ID: 16924032)
1. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.
Holsinger RM; Lee JS; Boyd A; Masters CL; Collins SJ
Neurology; 2006 Aug; 67(4):710-2. PubMed ID: 16924032
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
[TBL] [Abstract][Full Text] [Related]
3. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
[TBL] [Abstract][Full Text] [Related]
4. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
[TBL] [Abstract][Full Text] [Related]
5. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
[TBL] [Abstract][Full Text] [Related]
6. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
[TBL] [Abstract][Full Text] [Related]
7. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
Zhong Z; Ewers M; Teipel S; Bürger K; Wallin A; Blennow K; He P; McAllister C; Hampel H; Shen Y
Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
Blennow K; Johansson A; Zetterberg H
Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
12. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
[TBL] [Abstract][Full Text] [Related]
13. Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Cepek L; Steinacker P; Mollenhauer B; Wiese B; Ciesielczyk B; Bibl M; Wiltfang J; Zerr I; Schulz-Schaeffer W; Kretzschmar HA; Poser S; Otto M
Dement Geriatr Cogn Disord; 2005; 19(5-6):376-82. PubMed ID: 15802913
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
[TBL] [Abstract][Full Text] [Related]
15. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H; Shen Y
Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
[TBL] [Abstract][Full Text] [Related]
16. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
[TBL] [Abstract][Full Text] [Related]
17. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.
Lewczuk P; Kornhuber J; Vanderstichele H; Vanmechelen E; Esselmann H; Bibl M; Wolf S; Otto M; Reulbach U; Kölsch H; Jessen F; Schröder J; Schönknecht P; Hampel H; Peters O; Weimer E; Perneczky R; Jahn H; Luckhaus C; Lamla U; Supprian T; Maler JM; Wiltfang J
Neurobiol Aging; 2008 Jun; 29(6):812-8. PubMed ID: 17239996
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients.
Zanusso G; Fiorini M; Farinazzo A; Gelati M; Benedetti MD; Ferrari S; Dalla Libera A; Capaldi S; Monaco HL; Rizzuto N; Monaco S
Neurology; 2005 May; 64(9):1618-20. PubMed ID: 15883327
[TBL] [Abstract][Full Text] [Related]
19. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
